104 related articles for article (PubMed ID: 9160522)
1. The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse.
Hjorth RN; Bonde GM; Piner ED; Goldberg KM; Levner MH
Vaccine; 1997 Apr; 15(5):541-6. PubMed ID: 9160522
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
3. Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children.
Nolan T; Bravo L; Ceballos A; Mitha E; Gray G; Quiambao B; Patel SS; Bizjajeva S; Bock H; Nazaire-Bermal N; Forleo-Neto E; Cioppa GD; Narasimhan V
Vaccine; 2014 Oct; 32(46):6146-56. PubMed ID: 25223266
[TBL] [Abstract][Full Text] [Related]
4. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
[TBL] [Abstract][Full Text] [Related]
5. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
Ott G; Barchfeld GL; Van Nest G
Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
[TBL] [Abstract][Full Text] [Related]
7. Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge.
Sarkadi J; Kuti D; Jankovics M; Pallinger E; Fodor K; Kis Z; Gonczol E; Visontai I; Jankovics I
New Microbiol; 2017 Jul; 40(3):180-189. PubMed ID: 28675247
[TBL] [Abstract][Full Text] [Related]
8. Priming by a novel universal influenza vaccine (Multimeric-001)-a gateway for improving immune response in the elderly population.
Atsmon J; Caraco Y; Ziv-Sefer S; Shaikevich D; Abramov E; Volokhov I; Bruzil S; Haima KY; Gottlieb T; Ben-Yedidia T
Vaccine; 2014 Oct; 32(44):5816-23. PubMed ID: 25173483
[TBL] [Abstract][Full Text] [Related]
9. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera].
Kozlov VG; Viktorova EG
Vopr Virusol; 2011; 56(2):41-6. PubMed ID: 21545042
[TBL] [Abstract][Full Text] [Related]
11. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
Caillet C; Piras F; Bernard MC; de Montfort A; Boudet F; Vogel FR; Hoffenbach A; Moste C; Kusters I
Vaccine; 2010 Apr; 28(18):3076-9. PubMed ID: 20193791
[TBL] [Abstract][Full Text] [Related]
12.
Silveira F; Rivera-Patron M; Deshpande N; Sienra S; Checa J; Moreno M; Chabalgoity JA; Cibulski SP; Baz M
Front Immunol; 2023; 14():1163858. PubMed ID: 37197659
[TBL] [Abstract][Full Text] [Related]
13. Immune responses induced by prototype vaccines for AIDS in rhesus monkeys.
Ohkawa S; Wilson LA; Larosa G; Javaherian K; Martin LN; Murphey-Corb M
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):27-38. PubMed ID: 8179961
[TBL] [Abstract][Full Text] [Related]
14. A synthetic vaccine against influenza with built-in adjuvanticity.
Shapira M; Jolivet M; Arnon R
Int J Immunopharmacol; 1985; 7(5):719-23. PubMed ID: 4044097
[TBL] [Abstract][Full Text] [Related]
15. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.
Moreira LO; Smith AM; DeFreitas AA; Qualls JE; El Kasmi KC; Murray PJ
Vaccine; 2008 Oct; 26(46):5808-13. PubMed ID: 18789992
[TBL] [Abstract][Full Text] [Related]
16. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice.
Ben Ahmeida ET; Gregoriadis G; Potter CW; Jennings R
Vaccine; 1993 Oct; 11(13):1302-9. PubMed ID: 8296483
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects.
Frey SE; Reyes MR; Reynales H; Bermal NN; Nicolay U; Narasimhan V; Forleo-Neto E; Arora AK
Vaccine; 2014 Sep; 32(39):5027-34. PubMed ID: 25045825
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
Skowronski DM; Janjua NZ; De Serres G; Purych D; Gilca V; Scheifele DW; Dionne M; Sabaiduc S; Gardy JL; Li G; Bastien N; Petric M; Boivin G; Li Y
J Infect Dis; 2012 Dec; 206(12):1852-61. PubMed ID: 22872731
[TBL] [Abstract][Full Text] [Related]
19. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
van de Witte S; Nauta J; Montomoli E; Weckx J
Vaccine; 2018 Sep; 36(40):6030-6038. PubMed ID: 29709447
[TBL] [Abstract][Full Text] [Related]
20. Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection.
Masihi KN; Lange W; Schwenke S; Gast G; Huchshorn P; Palache A; Masek K
Vaccine; 1990 Apr; 8(2):159-63. PubMed ID: 2336875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
